Investigating treatments for stimulant use disorders like cocaine and methamphetamine addiction
Official title: Short-term Outcome of Stimulant Use Disorder Treatment Trials
Funded at Tulane University of Louisiana · NIH-11046075 · Data updated 2026-11-12
This study is looking at how well different treatments help people with cocaine and methamphetamine addiction by focusing on their cravings, to find out which medications might work best for lasting recovery.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $403,206 |
| NIH project number | 7R01DA054700-03 |
| Project ID | NIH-11046075 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals struggling with stimulant use disorders, particularly those using cocaine or methamphetamine.
✕Less likely to help
Patients who are not currently experiencing stimulant use disorders or those who have not engaged in stimulant use may not benefit from this research.
What this research studies
This research focuses on understanding the short-term outcomes of treatments for stimulant use disorders, particularly cocaine and methamphetamine addiction. It aims to explore drug craving as a key outcome, which is often linked to relapse in users. By analyzing data from previous short-term trials, the study seeks to identify effective medications that could lead to longer-term solutions. Patients may be monitored for their cravings and responses to various treatment approaches over a specified period.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective medications for treating stimulant use disorders, improving recovery outcomes for patients.
How similar studies have gone: While there have been numerous trials on stimulant use disorders, this specific focus on craving as a primary outcome is relatively novel and has not been extensively tested.
Where this research is happening
-
Tulane University of Louisiana
New Orleans, United States Active
Researchers
- Principal investigator: Mojtabai, Ramin — Tulane University of Louisiana
- Study coordinator: Mojtabai, Ramin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.